Ameritas Investment Company’s Cerence CRNC Stock Holding History

Ameritas Investment Company’s Portfolio CRNC Stock Details CRNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-15	Closed	–	–	547
2020 Q1	$0	Buy	+15	New	+$315	﹤0.01%	1767

Other funds holding CRNC

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Isomer Partners New York $74.3M AUM 23.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Ameritas Investment Company's CRNC Position: Q2 2020 in Review

Ameritas Investment Company sold out of Cerence (CRNC) in Q2 2020, closing a stake of 15 shares.

Ameritas Investment Company first reported a position in CRNC in Q1 2020 and held it in 1 quarter. The position peaked at $0 in Q1 2020. 241 funds tracked by Wall St. Rank hold CRNC as of Q2 2020.

Ameritas Investment Company reported no remaining Cerence position as of Q2 2020 after selling out during the quarter.
Ameritas Investment Company sold 15 Cerence shares in Q2 2020.
Ameritas Investment Company first reported a position in Cerence in Q1 2020 and held it in 1 quarter.
Ameritas Investment Company's Cerence position peaked at $0 in Q1 2020.
241 funds tracked by Wall St. Rank held Cerence as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.